Macrolides

Results: 352



#Item
1EISAI AND PIQUR SIGN LANDMARK COLLABORATION AGREEMENT TO INVESTIGATE HALAVEN® (ERIBULIN) AND PQR309 IN HARD TO TREAT FORM OF BREAST CANCER Agreement will see eribulin used in combination with novel PI3K/mTOR inhibitor i

EISAI AND PIQUR SIGN LANDMARK COLLABORATION AGREEMENT TO INVESTIGATE HALAVEN® (ERIBULIN) AND PQR309 IN HARD TO TREAT FORM OF BREAST CANCER Agreement will see eribulin used in combination with novel PI3K/mTOR inhibitor i

Add to Reading List

Source URL: www.piqur.com

Language: English - Date: 2016-02-17 03:09:52
2The brain sirolimus pills. Note: Any medical information published on this computer for up to 3 capsules of Xanax. The brain. To view content sources and attributions, refer to the increase in the past 14 days. Wenn Sie

The brain sirolimus pills. Note: Any medical information published on this computer for up to 3 capsules of Xanax. The brain. To view content sources and attributions, refer to the increase in the past 14 days. Wenn Sie

Add to Reading List

Source URL: pulseseismic.com

Language: English - Date: 2016-08-22 15:38:25
3Microsoft Word - 20160704_Opsiria_India

Microsoft Word - 20160704_Opsiria_India

Add to Reading List

Source URL: www.santen.com

Language: English - Date: 2016-07-01 05:29:33
4Beilage 1: Arzneimittelmonographien

Beilage 1: Arzneimittelmonographien

Add to Reading List

Source URL: www.sscc.ch

Language: English - Date: 2007-04-18 04:07:45
5Microsoft PowerPoint - PhilNat-ClinImmunmodulation2016 handout [Kompatibilitätsmodus]

Microsoft PowerPoint - PhilNat-ClinImmunmodulation2016 handout [Kompatibilitätsmodus]

Add to Reading List

Source URL: edit.cms.unibe.ch

Language: English - Date: 2016-05-26 09:57:43
6In renal transplant patients at high-immunologic risk •	 Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily mainten

In renal transplant patients at high-immunologic risk • Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily mainten

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2015-05-29 12:30:12
7•	  HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use TORISEL safely and effectively. See full prescribing information for TORISEL.

• HIGHLIGHTS OF PRESCRIBING INFORMATION These hig hlights do not include all the informatio n nee ded to use TORISEL safely and effectively. See full prescribing information for TORISEL.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2015-02-27 06:20:27
8HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFINITOR safely and effectively. See full prescribing information for AFINITOR. AFINITOR® (everolimus) tablets for

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFINITOR safely and effectively. See full prescribing information for AFINITOR. AFINITOR® (everolimus) tablets for

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2015-05-26 12:22:55
9MATEC Web of Conferences 4, DOI:   matecconf  C Owned by the authors, published by EDP Sciences, 2013

MATEC Web of Conferences 4, DOI:   matecconf  C Owned by the authors, published by EDP Sciences, 2013

Add to Reading List

Source URL: cea-proceedings.edpsciences.org

Language: English
10mTOR Signalling in Health and Disease  A brief history of TOR Robbie Loewith1 Department of Molecular Biology, National Centres of Competence in Research ‘Frontiers in Genetics’ and ‘Chemical Biology’, University

mTOR Signalling in Health and Disease A brief history of TOR Robbie Loewith1 Department of Molecular Biology, National Centres of Competence in Research ‘Frontiers in Genetics’ and ‘Chemical Biology’, University

Add to Reading List

Source URL: molbio.unige.ch

Language: English - Date: 2011-06-08 05:03:17